Welcome : Guest

HEMOGLOBIN A1C MONITORING - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 25 companies including many key and niche players such as -

Abbott Laboratories
Alere, Inc.
ARKRAY, Inc.
Beckman Coulter, Inc.
Bio-Rad Laboratories, Inc.

Click here to request a full list of companies covered in the report...

Code: MCP-1218
Price: $4950
Companies: 25
Pages: 266
Date: May 2016
Market Data Tables: 114
 



TABLE OF CONTENTS


  HEMOGLOBIN A1C MONITORING (Complete Report) Pages : 266   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definition and Scope of Study.....I-3  
   HbA1c Devices: Critical Role in Monitoring & Management of Diabetes.....II-11$100
   Growth Stimulants in a Nutshell.....II-2
Major Concerns.....II-2
POC-based HbA1c Testing Challenges the Dominance of Laboratory-based HbA1c Testing
  Market.....II-2
1$100
   Increasing Diabetes Prevalence & Need for Diabetes Management to Prop-up Demand for
  HbA1c Testing Devices.....II-3
2$200
   Table 1: Worldwide Prevalence of Diabetes: Number of Adults (20-79) with Diabetes in 2015 and 2040 (includes corresponding Graph/Chart).....II-5

Table 2: Global Prevalence (%) of Diabetes in Adults (20-79) by Region (2015 & 2040) (includes corresponding Graph/Chart).....II-5
1$350
   Table 3: Leading Countries by Health Expenditure on Diabetes (2015 & 2040) (in US$ Billion) (includes corresponding Graph/Chart).....II-61$350
   Table 4: Expenditure on Diabetes in Adult (20-79) as % of Total Healthcare Spending by Region (2015) (includes corresponding Graph/Chart).....II-71$350
   Table 5: Health Expenditure on Diabetes by Region: Average Diabetes-related Spending per Person with Diabetes in US$ for 2015 (includes corresponding Graph/Chart).....II-81$350
   Table 6: Health Expenditure on Diabetes (2015): Average Diabetes-related Spending per Person with Diabetes (US$) in Select Countries (includes corresponding Graph/Chart).....II-91$350
   High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices
  Market.....II-10
Table 7: Elderly Population (60+ Years) as a Percentage of Total Population (2015 & 2050) (includes corresponding Graph/Chart).....II-10
1$350
   Table 8: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart).....II-111$350
   Increasing Obesity Levels Underpins Market Growth.....II-12
Table 9: Global Obesity Epidemic: Percentage of Overweight, Obese, and Severely Obese Adults for 2014 & 2025 (includes corresponding Graph/Chart).....II-12
1$350
   Table 10: Severely Obese Population (in Thousands) Worldwide by Country: 2014 & 2025 (includes corresponding Graph/Chart).....II-13
Developing Nations: Growth Opportunities Abound for HbA1c Testing Market.....II-13
1$350
   Manufacturers Focus on Offering Products for Developing Markets.....II-14
Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market.....II-14
1$100
   Table 11: Global Per Capita Healthcare Spending (in US$) by Geographic Region for the Year 2014 (includes corresponding Graph/Chart).....II-151$350
   Table 12: Healthcare Spending as % of GDP by Geographic Region (2016E) (includes corresponding Graph/Chart).....II-16

Table 13: Top Countries with the Highest Per Capita Healthcare Spending (2014) (includes corresponding Graph/Chart).....II-16
1$350
   Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap.....II-17
Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?.....II-17
Technology Developments Transform Diagnostics in Diabetes Care.....II-17
1$100
   HbA1c Tests for Diabetes Diagnosis – Need to Address Issues Related to Hemoglobin
  Variants.....II-18
1$100
   Efforts Focus on Standardization Reporting of HbA1c Results.....II-191$100
   Consistent and Precise Test Results Favor Growth in the HbA1c Testing Devices
  Market.....II-20
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis.....II-20
Near Patient Testing Gaining Ground.....II-20
Despite Reliability Issues, Prospects Remain Positive for POC Testing Market.....II-20
1$100
   Advantages of POC HbA1c Tests over Lab Tests to Foster Adoption.....II-211$100
   Major Testing Methods in POC HbA1c Tests.....II-22
Immunoassays.....II-22
Boronate Affinity Chromatography.....II-22
1$100
   Micro-Optical Detection Methods.....II-23
Select HbA1c POC Tests in the Market - A Comparison.....II-23
1$100
   Home HbA1c Testing - Lack of Reimbursement Coverage & Accuracy Concerns Affect
  Adoption.....II-24
1$100
   Regular HbA1c Test Keeps Heart Risk at Bay.....II-25
Glycated Albumin – A Potential Threat to HbA1c?.....II-25
1$100
   Higher Levels of Glycosylated Hemoglobin Increases Risk of Death.....II-26
Non-Invasive Glucose Meters and CBGM Devices Threaten HbA1c Market.....II-26
2$200
   ESC and ADA Release Revised Guidelines for HbA1c Testing.....II-28
Study Finds Dentist Visits to be an Opportunity for HbA1c-based Diabetes Screening &
  Management.....II-28
1$100
   Competitive Landscape.....II-29
Table 14: Leading Players in the Global HbA1c Reagent Market (2015E): Percentage Breakdown of Revenues for Siemens and Others (includes corresponding Graph/Chart).....II-29
1$350
   Select Laboratory-based HbA1c Testing Products/Analyzers.....II-303$300
   Select Point of Care HbA1c Testing Products/Analyzers.....II-332$200
   What Causes Diabetes?.....II-35
Types of Diabetes.....II-35
1$100
   Major Types of Diabetes.....II-36
Likely Complications.....II-36
Nephropathy (Kidney Disease).....II-36
Diabetic Neuropathy (Nerve Damage).....II-36
1$100
   Retinopathy (Damage to the Eye and Blindness).....II-37
Poor Healing of Infections and Wounds.....II-37
Impotence in Men.....II-37
Periodontal Disease.....II-37
Cardiovascular Disease.....II-37
Interpreting the A1c Range.....II-37
1$100
   Blood Glucose Level Guidelines in the US.....II-38
A Glance at Key Diabetes Statistics.....II-38
Table 15: World Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart).....II-38

Table 16: Global Prevalence of Diabetes - Number of Adults Diagnosed with Diabetes (in Million) by Gender for 2015 & 2040 (includes corresponding Graph/Chart).....II-38
1$350
   Table 17: Worldwide Diabetes Prevalence (%) in Adults by Age Group and Gender (2015) (includes corresponding Graph/Chart).....II-39

Table 18: Number of Adults with Diagnosed Diabetes in Urban and Rural Areas (2015 & 2040) (in Million) (includes corresponding Graph/Chart).....II-39
1$350
   Table 19: Top 10 Countries with Highest Number of Adults Diagnosed with Diabetes (in Million) for 2015 & 2040 (includes corresponding Graph/Chart).....II-401$350
   Table 20: Proportion of Undiagnosed Diabetes Cases (20-79 Years) by Region (2015) (includes corresponding Graph/Chart).....II-41

Table 21: Proportion of Deaths on Account of Diabetes in People Aged Less than 60 Years by Region (2015) (includes corresponding Graph/Chart).....II-41
1$350
   Therapeutic Options for Diabetes.....II-42
Oral Medications for Type 2 Diabetes.....II-42
Side Effects of Insulin Therapy.....II-42
1$100
   Maintaining A1c Test Result Below 7%.....II-43
Common Diabetes Management Practices.....II-43
1$100
   Hemoglobin – A Brief.....II-44
Hemoglobin A1c- Description.....II-44
HbA1c Monitoring.....II-44
What is A1c?.....II-44
1$100
   1. HbA1c Laboratory Testing.....II-45
2. HbA1c Point of Care Testing & Self-Monitoring.....II-45
Hemoglobin A1c (HbA1c) Test.....II-45
1$100
   Interpreting HbA1c Test Readings.....II-46
Interpreting HbA1c Test Readings.....II-46
Result of Hemoglobin A1c Test.....II-46
Clinical Use of A1c Testing.....II-46
1$100
   Advantages of A1c Assessment & Interpretation.....II-47
Risks Associated with HbA1c Testing.....II-47
Methods of Measurement for Glycohemoglobin.....II-47
1$100
   Why Opt for HbA1c Testing?.....II-48
The Diabetes Control & Complications Trial (DCCT).....II-48
The Kumamoto and UK Prospective Studies.....II-48
Glycemia Tests Used in Monitoring Diabetes.....II-48
Urine Glucose Testing.....II-48
1$100
   Glycated Protein Testing.....II-49
Table 22: Relation Between A1c Level and Mean Plasma Glucose Levels.....II-49
HbA1c Test Types.....II-49
1$350
   HbA1c Laboratory Testing.....II-50
Analytical Techniques Used for Quantifying HbA1c in Labs.....II-50
Standardization of HbA1c Results.....II-50
1$100
   Table 23: CAP Accuracy Grading for HbA1c Measurements (2007-2013).....II-51
HbA1c Point of Care Testing & Self-Monitoring.....II-51
1$350
   Standardization of Glycated Hemoglobin Testing.....II-52
NGSP Standardization of HbA1c.....II-52
IFCC Standardization of HbA1c.....II-52
1$100
   HbA1c Reporting.....II-53
Table 24: A1c (%) and Corresponding eAG Number (in mg/dl or mmol/l).....II-53
1$350
   ARKRAY Unveils New Instruments for HbA1c Measurement.....II-54
Roche Introduces New Cobas C513 Analyser.....II-54
ARKRAY Launches B-analyst HbA1c Control for HbA1c Tests.....II-54
ARKRAY Unveils CinQ HbA1c Range of Reagent Kit.....II-54
Transasia Bio-Medicals Introduces HbA1c & HbA2/F-Fully Automated Analyzer.....II-54
ARKRAY Releases PocketChem A1c HbA1c Analyzer.....II-54
1$100
   Beckman Coulter Introduces Next-Generation Hemoglobin A1c.....II-55
ARKRAY Unveils ADAMS A1c mini Glycated-Hemoglobin Analyzer.....II-55
Axis-Shield Introduces HbA1c Turbidimetric Immunoassay.....II-55
Abbott Introduces New A1c Test for Diabetes Diagnosis.....II-55
Sanofi Introduces Self-Monitoring Device Offering HbA1c Values.....II-55
ARKRAY Unveils ADAMS Hybrid AH-8290 Dual HbA1c and Glucose Analyzer.....II-55
1$100
   ARKRAY Releases ADAMS A1c HA-8180V and ADAMS A1c HA-8180T Analyzers.....II-56
Sebia Unveils Capillarys HbA1c Assay.....II-56
1$100
   Siemens Healthcare Rebrands as Siemens Healthineers.....II-57
Sinocare to Acquire PTS Diagnostics.....II-57
Abbott Inks Definitive Agreement to Takeover Alere.....II-57
Bio-Rad Bags FDA Approval for D-100™ System for A1c Testing.....II-57
Bio-Rad’s VARIANT™ II TURBO HbA1c Kit – 2.0 Receives FDA Approval for Use in
  Diabetes Diagnosis.....II-57
1$100
   Abnova Concludes Clinical Trial for Personal A1c Diabetes Rapid Test.....II-58
Ortho-Clinical Diagnostics Obtains FDA Approval for VITROS® Chemistry Products HbA1c
  Reagent Kit.....II-58
Abbott Gains FDA Approval for ARCHITECT Clinical Chemistry HbA1c Test.....II-58
PTS Acquires Bayer’s A1CNow® Product Family.....II-58
Radiometer Acquires HemoCue.....II-58
BioHermes Acquires HbA1c Technology from Scripps Laboratories.....II-58
1$100
   Abbott Laboratories (US).....II-59
Alere, Inc. (US).....II-59
1$100
   ARKRAY, Inc. (Japan).....II-60
Beckman Coulter, Inc. (US).....II-60
1$100
   Bio-Rad Laboratories, Inc. (US).....II-61
Diazyme Laboratories Inc. (US).....II-61
1$100
   EKF Diagnostics Holdings Plc (UK).....II-62
HemoCue® AB (Sweden).....II-62
1$100
   Infopia Co., Ltd. (South Korea).....II-63
A.Menarini Diagnostics Ltd. (UK).....II-63
1$100
   PTS Diagnostics (US).....II-64
Roche Diagnostics (Switzerland).....II-64
Siemens Healthineers (Germany).....II-64
1$100
   Tosoh Bioscience, Inc. (US).....II-65
Trinity Biotech plc (Ireland).....II-65
1$100
   Table 25: World Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-661$350
   Table 26: World Historic Review for HbA1c Monitoring by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-671$350
   Table 27: World 14-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-681$350
   Table 28: World Recent Past, Current & Future Analysis for Laboratory-based HbA1c Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-691$350
   Table 29: World Historic Review for Laboratory-based HbA1c Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-701$350
   Table 30: World 14-Year Perspective for Laboratory-based HbA1c Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-711$350
   Table 31: World Recent Past, Current & Future Analysis for Point-of-Care (POC)-based HbA1c Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).....II-721$350
   Table 32: World Historic Review for Point-of-Care (POC)-based HbA1c Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).....II-731$350
   Table 33: World 14-Year Perspective for Point-of-Care (POC)-based HbA1c Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....II-741$350
   A. Market Analysis.....III-1
Outlook.....III-1
1$75
   Table 34: Diabetes Statistics in North America & Caribbean (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-21$200
   Table 35: Diabetes and Population Statistics in North America and Caribbean Region (2015 & 2040) (includes corresponding Graph/Chart).....III-3
Diabetes Statistics in the US – An Overview.....III-3
1$200
   Age Factor.....III-4
Table 36: Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Gender (includes corresponding Graph/Chart).....III-4

Table 37: Diabetes Prevalence in the US (2015E): Percentage Share of Number of Diabetics by Age Group (includes corresponding Graph/Chart).....III-4
Prevalence by Race/Ethnicity.....III-4
1$200
   Table 38: US Market for Diabetes (2012): Percentage Breakdown of Prevalence by Race/Ethnicity - Non-Hispanic Blacks and Non-Hispanic Whites (includes corresponding Graph/Chart).....III-5
Mean HbA1c Scores at National Level.....III-5
Economic Burden of Diabetes.....III-5
1$200
   Table 39: Direct Medical Expenditure on Diabetes Management in the US (2012): Percentage Share Breakdown of Costs Incurred by Component (includes corresponding Graph/Chart).....III-6

Table 40: Indirect Costs of Diabetes in the US (2012): Percentage Share Breakdown by Component (includes corresponding Graph/Chart).....III-6
1$200
   HbA1c – Increasingly Moving into Physician’s Office.....III-7
HbA1c Testing for Diabetes Detection Gains Support.....III-7
1$75
   ADA 2015 Diabetes Diagnostic Criteria.....III-8
A Glance at Past Recommendations of ADA for HbA1c Testing in Certain
  Patients.....III-8
Growing Inclination towards CLIA-Waived Tests.....III-8
Need for Further Stringency in Requirements Arises.....III-8
1$75
   Healthcare Reform Legislation: Impact on Diabetes Diagnostics.....III-91$75
   US Near Patient HbA1c Testing – A Highly Consolidated Market.....III-10
Table 41: Leading Players in the US Near Patient HbA1c Testing Market (2015E): Percentage Share Breakdown of Revenues for Alere, Siemens and Others (includes corresponding Graph/Chart).....III-10
1$200
   Product Approvals/Launches.....III-11
Strategic Corporate Developments.....III-11
2$150
   Key Players.....III-134$300
   B. Market Analytics.....III-17
Table 42: US Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-17
1$200
   Table 43: US Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-181$200
   Table 44: US 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-191$200
   A. Market Analysis.....III-20
Outlook.....III-20
Diabetes Statistics in Canada.....III-20
Table 45: Adult Diabetes in Canada (2015E): Percentage Share Breakdown of Diabetic Population by Gender (includes corresponding Graph/Chart).....III-20

Table 46: Adult Diabetes in Canada (2015E): Percentage Share Breakdown of Diabetic Population by Age Group (includes corresponding Graph/Chart).....III-20
1$200
   B. Market Analytics.....III-21
Table 47: Canadian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-21
1$200
   Table 48: Canadian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-221$200
   Table 49: Canadian 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-231$200
   A. Market Analysis.....III-24
Outlook.....III-24
Product Approvals/Launches.....III-24
1$75
   Arkray, Inc. – A Major Player.....III-251$75
   B. Market Analytics.....III-26
Table 50: Japanese Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-26
1$200
   Table 51: Japanese Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-271$200
   Table 52: Japanese 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-281$200
   A. Market Analysis.....III-29
Outlook.....III-29
Diabetes Diagnostics Market in Europe – A Promising Outlook.....III-29
1$75
   Proven Efficacy and Benefits of POCT HbA1C Tests Spur Adoption.....III-30
A Glance at Key Diabetes Statistics in Europe.....III-30
Table 53: Diabetes and Population Statistics in Europe (2015 & 2040) (includes corresponding Graph/Chart).....III-30
1$200
   Table 54: Diabetes Statistics in Europe (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-311$200
   B. Market Analytics.....III-32
Table 55: European Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-32
1$200
   Table 56: European Historic Review for HbA1c Monitoring by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-331$200
   Table 57: European 14-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-341$200
   Table 58: European Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-351$200
   Table 59: European Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-361$200
   Table 60: European 14-Year Perspective for HbA1c Monitoring by Segment -Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-371$200
   A. Market Analysis.....III-38
Outlook.....III-38
Strategic Corporate Developments.....III-38
1$75
   B. Market Analytics.....III-39
Table 61: French Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-39
1$200
   Table 62: French Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-401$200
   Table 63: French 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-411$200
   A. Market Analysis.....III-42
Outlook.....III-42
Strategic Corporate Development.....III-42
Siemens Healthineers – A Key Player.....III-42
1$75
   B. Market Analytics.....III-43
Table 64: German Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-43
1$200
   Table 65: German Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-441$200
   Table 66: German 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-451$200
   Market Analysis.....III-46
Table 67: Italian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-46
1$200
   Table 68: Italian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-471$200
   Table 69: Italian 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-481$200
   A. Market Analysis.....III-49
Outlook.....III-49
Diabetes Statistics & Management – An Insight.....III-49
Rising Obesity Cases – Increased Risk of Diabetes.....III-49
1$75
   Type 1 Diabetes in Children.....III-50
Table 70: Number of Children with Type 1 Diabetes in Select Countries (2015) (includes corresponding Graph/Chart).....III-50
NHS England Launches Action for Diabetes Plan.....III-50
1$200
   Product Launch.....III-51
Key Players.....III-51
2$150
   B. Market Analytics.....III-53
Table 71: UK Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-53
1$200
   Table 72: UK Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-541$200
   Table 73: UK 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-551$200
   Market Analysis.....III-56
Table 74: Spanish Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-56
1$200
   Table 75: Spanish Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-571$200
   Table 76: Spanish 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-581$200
   Market Analysis.....III-59
Market Analysis.....III-59
1$75
   Table 77: Russian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-601$200
   Table 78: Russian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-611$200
   Table 79: Russian 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-621$200
   A. Market Analysis.....III-63
Outlook.....III-63
Strategic Corporate Developments.....III-63
Key Players.....III-63
2$150
   B. Market Analytics.....III-65
Table 80: Rest of Europe Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-65
1$200
   Table 81: Rest of Europe Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-661$200
   Table 82: Rest of Europe 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-671$200
   A. Market Analysis.....III-68
Outlook.....III-68
Diabetes Statistics – An Overview.....III-68
1$75
   Table 83: Diabetes and Population Statistics in Western Pacific (2015 & 2040) (includes corresponding Graph/Chart).....III-691$200
   Table 84: Diabetes Statistics in Western Pacific (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-701$200
   Table 85: Diabetes and Population Statistics in South East Asia (2015 & 2040).....III-71

Table 86: Diabetes Statistics in South East Asia (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-71
1$200
   B. Market Analytics.....III-72
Table 87: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-72
1$200
   Table 88: Asia-Pacific Historic Review for HbA1c Monitoring by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-731$200
   Table 89: Asia-Pacific 14-Year Perspective for HbA1c Monitoring by Geographic Region - Percentage Breakdown of Dollar Sales for China, India and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-741$200
   Table 90: Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-751$200
   Table 91: Asia-Pacific Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-761$200
   Table 92: Asia-Pacific 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-771$200
   A. Market Analysis.....III-78
Outlook.....III-78
Rising Diabetes Incidence Spurs Growth in Diabetes Diagnostics Market.....III-78
1$75
   B. Market Analytics.....III-79
Table 93: Chinese Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-79
1$200
   Table 94: Chinese Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-801$200
   Table 95: Chinese 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-811$200
   A. Market Analysis.....III-82
Outlook.....III-82
HbA1c Testing on Growth Spree.....III-82
Growth Stimulants & Challenges in a Nutshell.....III-82
1$75
   Rising Diabetes Cases – Opportunities for HbA1c Monitoring Market.....III-83
Product Launch.....III-83
1$75
   B. Market Analytics.....III-84
Table 96: Indian Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-84
1$200
   Table 97: Indian Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-851$200
   Table 98: Indian 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-861$200
   A. Market Analysis.....III-87
Outlook.....III-87
An Insight into Diabetes Statistics in Australia.....III-87
Table 99: Diabetes Population in Australia (2015): Percentage Share Breakdown of Number of Diabetics by Age Group (includes corresponding Graph/Chart).....III-87
1$200
   Strategic Corporate Development.....III-88
Infopia Co., Ltd. (South Korea) – A Major Player.....III-88
1$75
   B. Market Analytics.....III-89
Table 100: Rest of Asia-Pacific Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-89
1$200
   Table 101: Rest of Asia-Pacific Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-901$200
   Table 102: Rest of Asia-Pacific 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-911$200
   A. Market Analysis.....III-92
Outlook.....III-92
Diabetes in Latin America – A Glance at Key Statistics.....III-92
Table 103: Diabetes and Population Statistics in Central and South America (2015 & 2040) (includes corresponding Graph/Chart).....III-92
1$200
   Table 104: Diabetes Statistics in South & Central America (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-931$200
   B. Market Analytics.....III-94
Table 105: Latin American Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-94
1$200
   Table 106: Latin American Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-951$200
   Table 107: Latin American 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-961$200
   A. Market Analysis.....III-97
Outlook.....III-97
Diabetes Statistics in Africa and the Middle East.....III-97
Table 108: African Diabetes and Population Statistics (2015 & 2040) (includes corresponding Graph/Chart).....III-97
1$200
   Table 109: Diabetes Statistics in Africa (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-981$200
   Table 110: Diabetes and Population Statistics in Middle East and North Africa (2015 & 2040) (includes corresponding Graph/Chart).....III-991$200
   Table 111: Diabetes Statistics in Middle East and North Africa (2015) - Number of Adults with Diabetes (in 000s), Diabetes Prevalence (%) and Number of Diabetes-Related Deaths (in ‘000s) for Select Countries (includes corresponding Graph/Chart).....III-1001$200
   B. Market Analytics.....III-101
Table 112: Rest of World Recent Past, Current & Future Analysis for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2015 through 2022 (includes corresponding Graph/Chart).....III-101
1$200
   Table 113: Rest of World Historic Review for HbA1c Monitoring by Segment - Laboratory Testing and Point of Care Testing Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2009 through 2014 (includes corresponding Graph/Chart).....III-1021$200
   Table 114: Rest of World 14-Year Perspective for HbA1c Monitoring by Segment - Percentage Breakdown of Dollar Sales for Laboratory Testing and Point of Care Testing Markets for years 2009, 2016 & 2022 (includes corresponding Graph/Chart).....III-1031$200
  
Total Companies Profiled: 26 (including Divisions/Subsidiaries - 33)

Region/Country Players

The United States 15 Japan 2 Europe 13 Germany 3 The United Kingdom 4 Italy 1 Rest of Europe 5 Asia-Pacific (Excluding Japan) 3
Click here to request a full table of contents and more details on this project.